- Summits
- Sponsorship
- Media Opportunities
- News
- About
MedTech World alumnus Luminoah has reached a new milestone, receiving clearance from the U.S. Food and Drug Administration for its Luminoah Flow™ enteral nutrition system. The company focuses on modernizing enteral nutrition and is now preparing for its next phase following this regulatory milestone.
At MedTech World Europe 2025, Luminoah was recognised with the MedTech Startup of the Year award, an accolade that highlights a startup demonstrating strong innovation and growth potential. The latest regulatory milestone underscores that trajectory, as the company moves from recognition to real-world clinical impact.
Luminoah Flow is designed to improve the experience of patients who rely on tube feeding by combining portability, precision, and connected technology in a single system. The device provides real-time data access, simplifies workflows for clinicians, and supports greater mobility and independence for patients in everyday settings.
For Neal Piper, Founder and Chief Executive Officer of Luminoah, the clearance reflects years of work shaped by personal experience.
“FDA clearance of Luminoah Flow marks a major milestone in our mission to transform enteral nutrition,” he said. “Inspired by my family’s experience, we built Luminoah to address persistent challenges faced by patients and caregivers. Patients living with feeding tubes need solutions that integrate more naturally into daily life, and Luminoah Flow brings together modern technology and patient centered design to better support patients, caregivers, and clinicians.”
Clinicians point to a long-standing gap in enteral care once patients transition out of hospital environments. Dr. Gary Nace Jr., Pediatric Surgeon at Children’s Hospital of Philadelphia, noted:
“One of the biggest gaps in enteral care today is limited visibility once patients leave the hospital. Clinicians often rely on reported information rather than objective data when managing nutrition outside the hospital. A system like Luminoah Flow may help provide greater visibility into what is being delivered at home and support more informed clinical decision making.”
That sentiment is echoed by Tegan Medico, Clinical Dietitian at UVA Health, who highlighted the broader context of enteral nutrition:
“Enteral nutrition is a critical therapy for millions of patients, yet the technology supporting it has changed very little over time. Much of the burden still falls on patients and caregivers to manage feeds and communicate what is happening at home. A system like Luminoah Flow may help bring greater simplicity and visibility to that process, allowing clinicians to better support patients between visits.”
The Luminoah Flow system incorporates several features aimed at improving usability and care continuity:
“This clearance reflects the work our team has put into solving a deeply important problem,” said Garrett Marin, Chief Operating Officer at Luminoah. “We are excited to bring a solution to market that meets regulatory standards while improving day to day care for patients and providers.”
With FDA clearance secured, Luminoah is preparing for a phased commercial rollout across the United States. The company plans to work closely with healthcare providers, home health organizations, and patient communities as it introduces the system into clinical practice. Headquartered in Charlottesville, Virginia, Luminoah is one of several MedTech World alumni companies advancing toward regulatory milestones and market entry.
From breakthrough devices to regulatory milestones, the conversations around MedTech continue at MedTech World North America 2026, taking place from May 11 to 13. Explore the agenda, connect with industry leaders, and secure your place to be part of what’s ahead.
